In-vitro pH-responsive release of imatinib from iron-supplement coated anatase TiO
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
17 03 2022
17 03 2022
Historique:
received:
24
10
2021
accepted:
03
02
2022
entrez:
18
3
2022
pubmed:
19
3
2022
medline:
6
5
2022
Statut:
epublish
Résumé
Targeted drug delivery is one such precision method of delivering medication inside the human body which can vanquish all the limitations of the conventional chemotherapeutic techniques. In the present study, two types of nanoparticles (NPs) were chosen for the in-vitro pH-responsive release study of the drug, Imatinib, namely anatase Titanium Dioxide nanoparticles (TiO
Identifiants
pubmed: 35301335
doi: 10.1038/s41598-022-08090-7
pii: 10.1038/s41598-022-08090-7
pmc: PMC8931044
doi:
Substances chimiques
titanium dioxide
15FIX9V2JP
Imatinib Mesylate
8A1O1M485B
Titanium
D1JT611TNE
Iron
E1UOL152H7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4600Informations de copyright
© 2022. The Author(s).
Références
Pediatr Res. 2009 Aug;66(2):121-7
pubmed: 19390491
PLoS One. 2015 Jun 02;10(6):e0126874
pubmed: 26035710
Oncol Rep. 2016 Jan;35(1):197-204
pubmed: 26499059
Antioxidants (Basel). 2021 May 28;10(6):
pubmed: 34071500
Recent Results Cancer Res. 2018;212:1-27
pubmed: 30069623
Saudi J Biol Sci. 2020 Dec;27(12):3581-3592
pubmed: 33304169
Pharmacol Ther. 2021 Jun;222:107795
pubmed: 33358928
Leukemia. 2022 Jan;36(1):1-12
pubmed: 34561557
Curr Drug Targets. 2021;22(8):947-966
pubmed: 33511953
Semin Cancer Biol. 2020 Oct;65:13-27
pubmed: 31362073
Nat Rev Mater. 2021 Apr;6(4):351-370
pubmed: 34950512
Heliyon. 2021 Mar 16;7(3):e06514
pubmed: 33786399
Expert Opin Drug Deliv. 2019 Apr;16(4):331-345
pubmed: 30807242
Biomed Pharmacother. 2018 Jul;103:1018-1027
pubmed: 29710659
Biol Trace Elem Res. 2003 Winter;96(1-3):117-23
pubmed: 14716090
Nanomaterials (Basel). 2021 Feb 05;11(2):
pubmed: 33562669
Nutrients. 2019 Feb 25;11(2):
pubmed: 30823595